Lenient versus Strict Rate Control in Patients with Atrial Fibrillation
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Rate control is often the therapy of choice for atrial fibrillation. Guidelines recommend strict rate control, but this is not based on clinical evidence. We hypothesized that lenient rate control is not inferior to strict rate control for preventing cardiovascular morbidity and mortality in patients with permanent atrial fibrillation. METHODS: We randomly assigned 614 patients with permanent atrial fibrillation to undergo a lenient rate-control strategy (resting heart rate <110 beats per minute) or a strict rate-control strategy (resting heart rate <80 beats per minute and heart rate during moderate exercise <110 beats per minute). The primary outcome was a composite of death from cardiovascular causes, hospitalization for heart failure, and stroke, systemic embolism, bleeding, and life-threatening arrhythmic events. The duration of follow-up was at least 2 years, with a maximum of 3 years. RESULTS: The estimated cumulative incidence of the primary outcome at 3 years was 12.9% in the lenient-control group and 14.9% in the strict-control group, with an absolute difference with respect to the lenient-control group of -2.0 percentage points (90% confidence interval, -7.6 to 3.5; P<0.001 for the prespecified noninferiority margin). The frequencies of the components of the primary outcome were similar in the two groups. More patients in the lenient-control group met the heart-rate target or targets (304 [97.7%], vs. 203 [67.0%] in the strict-control group; P<0.001) with fewer total visits (75 [median, 0], vs. 684 [median, 2]; P<0.001). The frequencies of symptoms and adverse events were similar in the two groups. CONCLUSIONS: In patients with permanent atrial fibrillation, lenient rate control is as effective as strict rate control and is easier to achieve. (ClinicalTrials.gov number, NCT00392613.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There was no difference in a composite of clinical events (14.9% in the strict rate control group, 12.9% in the lenient group), 560 NYHA class, or hospitalizations.560, 561”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [560]
Citations
Cites
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Self-citationVan Gelder, I. C., Hagens, V. E., Bosker, H. A., Kingma, J. H., Kamp, O., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,359
Self-citationEffect of Dronedarone on Cardiovascular Events in Atrial Fibrillation
Hohnloser, S. H., Crijns, H. J. G. M., van Eickels, M., Gaudin, C., Page, R. L., Torp-Pedersen, C., & Connolly, S. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803778 · Cited by 1,129
Self-citationAtrial Fibrillation and Heart Failure: Treatment Considerations for a Dual Epidemic
Anter, E., Jessup, M., & Callans, D. J. (2009) · Circulation · doi:10.1161/circulationaha.108.821306 · Cited by 678
Lechat, P., Hulot, J.-S., Escolano, S., Mallet, A., Leizorovicz, A., Werhlen-Grandjean, M., Pochmalicki, G., & Dargie, H. (2001) · Circulation · doi:10.1161/01.cir.103.10.1428 · Cited by 525
Nerheim, P., Birger-Botkin, S., Piracha, L., & Olshansky, B. (2004) · Circulation · doi:10.1161/01.cir.0000135472.28234.cc · Cited by 378
Van Gelder, I. C., Crijns, H. J. G. M., Blanksma, P. K., Landsman, M. L. J., Posma, J. L., Van Den Berg, M. P., Meijler, F. L., & Lie, K. I. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90352-d · Cited by 269
Self-citationConnolly, S. J., Crijns, H. J. G. M., Torp-Pedersen, C., van Eickels, M., Gaudin, C., Page, R. L., & Hohnloser, S. H. (2009) · Circulation · doi:10.1161/circulationaha.109.875252 · Cited by 261
Self-citation
Cited by
Items 801–900 of 999
Atrial Fibrillation and Cardiac Resynchronization Therapy: How Should Rate be Controlled?
Rienstra, M. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs028
“reduce heart rate in the majority of patients with AF; however, strict rate control targets are difficult to reach in about one-third of patients, mainly because of side effects of drugs.(13) Ablation of the atrioventricular node is most effective since the atria are”
BackgroundRate versus rhythm in atrial fibrillation: and how slow do you go?
Allan, G. M., Korownyk, C. S., & Kolber, M. R. (2011) · Europe PMC (PubMed Central)
Studies of risks associated with atrial fibrillation
Olsson, L. (2010) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Leclerc, V., Gilbert, S., & Drolet, B. (2012) · Pharmactuel
de Isla, L. P., Bayés‐Genís, A., Sanchís, J. M., & Heras, M. (2010) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(10)70144-4 · Cited by 1
Kim, D., & Lee, M. (2014) · Korean Journal of Medicine · doi:10.3904/kjm.2014.87.1.26
“전이나 증상이 없는 환자에서 적극적인 박동수 조절의 의미 도 퇴색하게 되었다[10].”
Beleslin, B., Deljanin, M., Kanjuh, V., Parapid, B. J., Giga, V. L., Prostran, M. S., Angelkov, L., Balinovac, J., Bikicki, M., Ambrosio, G., et al. (2013)
Atrial Fibrillation and Supraventricular Tachycardias
Fan, R., & Rashba, E. J. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4441-0_8
The strategies of treatment of atrial fibrillation in the elderly
Bogołowska-Stieblich, A., Kusz‐Rynkun, A., & Tałałaj, M. (2015) · Postępy Nauk Medycznych
Relationship between 24- hour Holter variables, chest discomfort and syncope: Does age matter?
Saha, S. K. (2015) · International Cardiovascular Forum Journal · doi:10.17987/icfj.v1i2.28
Giner‐Soriano, M., Roso‐Llorach, A., Urgell, C. V., Casellas, A., González, I. F., Capellà, D., & Morros, R. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.02.002
Practical Management of Atrial Fibrillation
Delaughter, M. C., Macle, L., Ranjan, R., & Sandesara, C. M. (2014)
Updates in the Management of Atrial Fibrillation
Martinez, M. W. (2013)
Gillis, A. M., & Skanes, A. C. (2011)
Controlling Atrial Fibrillation
Joy, S. D. S. (2010) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000389671.85982.59
Step by step towards a clinical pathway
Zwaan, E., & Umans, V. A. W. M. (2012) · International Journal of Care Coordination · doi:10.1258/jicp.2012.010031
Management Options in Atrial Fibrillation – The Role of Vernakalant
Hohnloser, S. H., & Omar, S. A. (2012) · European Journal of Cardiovascular Medicine · doi:10.5083/ejcm.20424884.61
Prise en charge de la fibrillation auriculaire en 2011 Management of atrial fibrillation in 2011
Catez, E., Sina, B., Peperstraete, B., Ngoc, E. T., Castro, J. V. D. M., Morissens, M., Flores, G., Strachinaru, M., & Verbeet, T. W. (2011)
Vorhofflimmern und Herzinsuffizienz
Altmann, D., & Rickli, H. (2015) · Cardiovascular Medicine · doi:10.4414/cvm.2015.00302 · Cited by 1
Rate Control for Atrial Fibrillation: Can We Relax?
Link, M. S. (2010) · Journal watch · doi:10.1056/jc201003150000001
Therapie des Vorhofflimmern beim kritisch Kranken
Trappe, H., & Heinroth, H. (2012)
Katheterablation bei Vorhofflimmern
Stöckigt, F., & SCHRICKEL, J. W. (2015) · CardioVasc · doi:10.1007/s15027-015-0686-9
Liew, R. (2012) · The Egyptian Heart Journal · doi:10.1016/j.ehj.2012.02.007
[Atrial fibrillation: recent progress].
Casado Arroyo, R., & van de Borne, P. (2014) · PubMed
Traitement antiarythmique de la fibrillation auriculaire
Saoudi, N. C. (2011) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32049-7
Lenient versus Strict Rate Control in Atrial Fibrillation
Grimsley, E. W., Patel, R., & Persed, P. (2010) · New England Journal of Medicine · doi:10.1056/nejmc1005799
Diagnostik und Behandlung von Vorhofflimmern: Aktuelle Empfehlungen für die Praxis
Kirchhof, P. F. (2015) · CME · doi:10.1007/s11298-015-1100-8
Atrial Fibrillation and Heart Failure: Medical Management and Catheter Ablation
Sauer, A. J., & Knight, B. P. (2016) · Springer eBooks · doi:10.1007/978-1-4471-4279-9_13
Therapie tachykarder Herzrhythmusstörungen
Tebbenjohanns, J., & Rühmkorf, K. (2016) · CME · doi:10.1007/s11298-016-5547-z
Oral, H., & Latchamsetty, R. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2856-5.00075-3
Outpatient Medications in Atrial Fibrillation
Newby, L. K., & Pokorney, S. D. (2016) · Contemporary cardiology · doi:10.1007/978-3-319-31386-3_18
Rotors in Human Atrial Fibrillation
Narayan, S. M., & Rappel, W. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2856-5.00043-1
Fibrillation et flutter auriculaires: si semblables et si différents!
Noti, F., & Fuhrer, J. (2015) · Forum Médical Suisse ‒ Swiss Medical Forum · doi:10.4414/fms.2015.02377
“Les patients ne souffrant pas d’insuffisance cardiaque avec fonction ventriculaire gauche préservée devraient atteindre une fréquence cardiaque moyenne de 85/min, comme cela était le cas dans une étude très remarquée pour laquelle une fréquence cible <110/min avait été visée [8].”
BackgroundPitfalls in the Acute Management of Atrial Fibrillation
Winchester, D. E., Kaufmann, M. R., McKillop, M., & Miles, W. M. (2016) · Contemporary cardiology · doi:10.1007/978-3-319-31386-3_14
Still many unanswered questions about rate control therapy in atrial fibrillation
Kloosterman, M., & Gelder, I. C. V. (2016) · BMJ Evidence-Based Medicine · doi:10.1136/ebmed-2016-110413
“RACE II showed that a lenient approach to rate control is easy, safe and effective and should be considered as an initial approach for those with few symptoms.(2) However, randomised controlled trials on selecting rate controlling drugs are lacking.”
BackgroundCommon Postoperative and Inpatient Issues
Brady, P. C., & Guseh, J. S. (2016) · Springer eBooks · doi:10.1007/978-3-319-27724-0_14
Martsevich, S. Y., & Lukina, Y. V. (2011) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2011-7-6-770-774
Advances in the Pharmacologic of Atrial Fibrillation
Burashnikov, A., & Antzelevitch, C. N. (2011)
What should a general practitioner know about the diagnosis and treatment of atrial fibrillation
Heinc, P., Kamasova, M., Látal, J., Kováčik, F., Smékal, A., & Rec, L. (2016) · Medicína pro praxi · doi:10.36290/med.2016.035
Transcatheter Ablation of Atrial Fibrillation in Patients with Chronic Heart Failure
Monaco, A. D., Quadrini, F., Vitulano, N., & Grimaldi, M. (2017) · InTech eBooks · doi:10.5772/67024
DESFECHOS E FATORES PROGNÓSTICOS DE PACIENTES COM FIBRILAÇÃO ATRIAL
Heinisch, R. H., Leal, F. M., Hoffmann, J., & Favretto, G. E. D. (2016) · Arquivos Catarinenses de Medicina · doi:10.63845/709fnn94
OBSOLETE: Clinical Trials for Atrial Fibrillation - What do we know?
Wilton, S. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99783-6
Atrial Fibrillation and Other Supraventricular Tachycardias
Sedehi, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-43341-7_16
ESC-Leitlinie 2016 zum Management von Vorhofflimmern
Deneke, T., Nentwich, K., Sonne, K., Fochler, F., Ene, E., & Halbfaß, P. (2017) · Aktuelle Kardiologie · doi:10.1055/s-0043-109375
“[44] Van Gelder IC, Greonveld HF, Crijns HJ et al.”
BackgroundSudden Cardiac Death and Dysrhythmia in Hemodialysis Patients
Hase, H. (2012) · Japanese Journal of Electrocardiology · doi:10.5105/jse.32.321
Breitenstein, A., & Steffel, J. (2017) · Praxis · doi:10.1024/1661-8157/a002725
Guía de práctica clínica para tratamiento de fibrilación auricular
Forero, V. H. (2015) · Revista Cuarzo · doi:10.26752/cuarzo.v21.n1.33
“C” Trouble: Class IC Anti-arrhythmic Toxicity
Eng, M., Wung, W., Srivatsa, U. N., & Singh, G. D. (2017) · Journal of Cardiovascular Medicine and Cardiology · doi:10.17352/2455-2976.000047
“Due to improved quality of life, rhythm control is a common treatment strategy [2,3].”
BackgroundAtrial Fibrillation : treatment, associated conditions and quantification of symptoms
Höglund, N. (2017) · DiVA at Umeå University (Umeå University)
Clinical Management of Atrial Fibrillation
Heist, E. K., MANSOUR, M. C., & Ruskin, J. N. (2017) · Cardiovascular medicine · doi:10.1007/978-3-319-58000-5_15
Marshall, N. (2017) · Physician Assistant Clinics · doi:10.1016/j.cpha.2017.06.002
Special Problems in Management of Atrial Fibrillation in the Elderly
Menon, S. M. D. (2017) · Springer eBooks · doi:10.1007/978-981-10-3253-0_15
Park, H., & Han, S. (2017) · Korean Circulation Journal · doi:10.4070/kcj.2017.0304
Sychov, O. S., Romaniuk, P. B., Срібна, О. В., & Hurianov, V. H. (2017) · Здобутки клінічної і експериментальної медицини · doi:10.11603/1811-2471.2017.v1.i3.8175 · Cited by 2
Juhász, V. (2017) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.4039
Bunin, Y. А., & Miklishanskaya, S. V. (2017) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2017-13-6-856-862
Fibrillation atriale du sujet âgé
Friocourt, P., & Belmin, J. (2018)
ALTERNATIVAS TERAPÉUTICAS EN FIBRILACIÓN AURICULAR
Altamirano, R. (2018) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2018.02.008
“71 En el estudio RACE II se comparó una estrategia de control de frecuencia estricta (FC en reposo <80lpm) contra una más permisiva (FC en reposo <110 lpm), sin encontrarse diferencias en desarrollo de comorbilidad cardiovascular, sintomatología, QOL o mortalidad (6).”
BackgroundAtrial Fibrillation Management in Emergency Departments: A New Protocol Assessment
Marchetti, M. (2018) · Journal of Anesthesia & Intensive Care Medicine · doi:10.19080/jaicm.2018.05.555675
“It is associated with a diminution in morbidity and in rate of hospitalization [13,14].”
BackgroundPostoperative atrial fibrillation in thoracic surgery
Yokota, T. (2018) · Journal of the Japanese Society of Intensive Care Medicine · doi:10.3918/jsicm.25_171
CT in the Management of Cardiac Arrhythmias
Wilson, J. R., Saremi, F., Narula, J., & Narayan, S. M. (2017) · Springer eBooks · doi:10.1007/978-1-4471-7357-1_14
Stroke prevention: antiarrhythmic treatments
Camm, A. J., & Savelieva, I. (2012) · doi:10.2217/ebo.12.45
Aspects of antithrombotic therapy in patients with atrial fibrillation and coronary disease
Bockeria, O. L., & Собирджонович, Г. Ф. (2018) · Annaly aritmologii · doi:10.15275/annaritmol.2018.1.6
“, у пациентов с постоянной формой фибрилляции предсердий распространенность ИБС составила 18% [10].”
Fukuzawa, Y., Yoshitomi, A., Imokawa, S., & Kubota, T. (2017) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.106.1491
Fibrilación auricular en el anciano
Friocourt, P., & Belmin, J. (2018) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(18)91426-1
Copyright and licensing of E-journals: Perspective from E-journals in J-STAGE
Ikeda, T. (2018) · Japanese Journal of Electrocardiology · doi:10.5105/jse.38.221
Kotecha, D., Senoo, K., & Lip, G. Y. H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00147-5
Sychov, O. S., Romaniuk, P. B., & Hurianov, V. H. (2019) · Здобутки клінічної і експериментальної медицини · doi:10.11603/1811-2471.2018.v0.i4.9744
Rienstra, M., Kotecha, D., & van Veldhuisen, D. J. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1425
Atrial Fibrillation: Patient Visit Checklist
Kohli, P. (2013)
Barmano, N. (2019) · Linköping University medical dissertations · doi:10.3384/diss.diva-156364 · Cited by 1
Evaluación diagnóstica y manejo terapéutico farmacológico en pacientes con fibrilación auricular
Sequeira, O. R., Torales, J. M., García, L. B., & Centurión, O. A. (2019) · Memorias del Instituto de Investigaciones en Ciencias de la Salud · doi:10.18004/mem.iics/1812-9528/2019.017.02.86-101 · Cited by 4
Wearable Cardioverter-Defibrillators
ADELSTEIN, E. C., Wang, N. C., & Saba, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-22882-8_3
The antithrombotic therapy of atrial fibrillation in patients with coronary heart disease
Bockeria, O. L., & Le, T. G. (2018) · Russian Open Medical Journal · doi:10.15275/rusomj.2018.0412
Herzinsuffizienz und Arrhythmien
Stellbrink, C. (2019) · Aktuelle Kardiologie · doi:10.1055/a-1027-6448
“[25] Van Gelder IC, Groenveld HF, Crijns HJGM et al.”
BackgroundVI. Rate Control Therapy: Therapeutic Target and Use Drugs
Ikeda, T. (2019) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.108.234
Bockeria, L. A., Шалов, Р. З., Филатов, А. Г., Goryachev, V. A., & Сабиров, Ш. Н. (2019) · Annaly aritmologii · doi:10.15275/annaritmol.2019.4.1
Кanorskiy, S. G., & Polischuk, L. V. (2020) · Kardiologiia · doi:10.18087/cardio.2020.3.n870
Atrial fibrillation, what exactly do we know? (English version)
Huang, C. (2019) · International Journal of Heart Rhythm · doi:10.4103/ijhr.ijhr_4_20
Rate control of atrial fibrillation
Kloosterman, M., & Gelder, I. C. V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817728-0.00042-5
Atrial Fibrillation and Atrial Flutter
Kaplinskiy, V., & Gelfand, E. V. (2020) · Springer eBooks · doi:10.1007/978-3-030-47868-1_3
Management of Arrhythmias and Device Therapy in Heart Failure
Ferguson, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-60987-6.00038-7
Riddle, M., McCallum, R. W., Ojha, C. P., Paul, T. K., Gupta, V., Baran, D. A., Prakash, B. V., Misra, A., Mares, A. C., Abedin, M., et al. (2020) · Journal of Investigative Medicine · doi:10.1136/jim-2020-001500
Connecting the dots? Rate control, heart failure, and atrial fibrillation
Toennis, T., & Kirchhof, P. F. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa354
Is an underlying cardiac condition causing your patient’s palpitations?
Narducci (2021) · The Journal of Family Practice · doi:10.12788/jfp.0152
Fibrilación auricular (Segunda Parte)
Ciapponi, A. (2013) · Evidencia actualizacion en la práctica ambulatoria · doi:10.51987/evidencia.v16i3.6202
Current Status of Rate Control for Clinical Management of Patients with Atrial Fibrillation
Ikeda, T. (2014) · Japanese Journal of Electrocardiology · doi:10.5105/jse.33.458
Vorhofflimmern – was wir nicht wissen („gaps in evidence“)
Wiedmann, F., & Schmidt, C. (2021) · Aktuelle Kardiologie · doi:10.1055/a-1378-7400
Management des Vorhofflimmerns: Prognoseverbesserung nach Pulmonalvenenisolation?
Hartmann, J., Gunawardene, M., Jularic, M., Eickholt, C., & Willems, S. (2021) · Aktuelle Kardiologie · doi:10.1055/a-1479-2430
“[4] Van Gelder , I, Groenveld H, Crijns H et al.”
BackgroundVerdonschot, J. A. J. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210108jv
Aplicación de nuevos biomarcadores en el estudio de pacientes con fibrilación auricular persistente
Merino, A. F. (2021) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/47788
Is there a role for verapamil beyond rate control in paroxysmal atrial fibrillation?
Benz, A. P., & Hohnloser, S. H. (2021) · EP Europace · doi:10.1093/europace/euab225
Kobalava, Z. D., & Анатольевич, Ш. А. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4653
Seizer, P., & Gramlich, M. (2021) · Kardiologie up2date · doi:10.1055/a-1151-1623
Metadata
- Authors
- Van Gelder, I. C., Groenveld, H. F., Crijns, H. J. G. M., Tuininga, Y. S., Tijssen, J. G. P., Alings, A. M., Hillege, H. L., Bergsma-Kadijk, J. A., Cornel, J. H., Kamp, O., Tukkie, R., Bosker, H. A., Van Veldhuisen, D. J., & Van den Berg, M. P.
- Affiliations
- University Medical Center Groningen (NL)
- Maastricht University Medical Centre (NL)
- Deventer Ziekenhuis (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Medisch Centrum Alkmaar (NL)
- Rijnstate Hospital (NL)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-04-15
- Volume
- 362
- Issue
- 15
- Pages
- 1363-1373
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2102129403
- Cited by
- 1,033
- References
- 19
- Citations by year
- 2026: 36 · 2025: 55 · 2024: 59 · 2023: 61 · 2022: 56 · 2021: 63 · 2020: 44 · 2019: 50 · 2018: 45 · 2017: 62 · 2016: 56 · 2015: 51 · 2014: 81 · 2013: 94 · 2012: 83
- FWCI
- 68.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- atrial fibrillation, rate control, resting heart rate, non-inferiority, cardiovascular morbidity and mortality, heart failure hospitalization, stroke, hemorrhage, arrhythmic events, anticoagulation
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Anti-Arrhythmia Agents, Atrial Fibrillation, Calcium Channel Blockers, Female, Follow-Up Studies, Heart Rate, Humans, Male, Middle Aged, Confidence Intervals, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.